These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8744629)

  • 1. Resolution of pyoderma gangrenosum using tacolimus (FK-506).
    Cooley HM; Castelino D; McNair P; Russell DM; Chohan V; Kay TW
    Aust N Z J Med; 1996 Apr; 26(2):238-9. PubMed ID: 8744629
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum.
    Richter-Hintz D; Schuppe HC; Homey B; Lehmann P; Ruzicka T
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):304-5. PubMed ID: 10642695
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum.
    Weichert G; Sauder DN
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):648-50. PubMed ID: 9777778
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus for pyoderma gangrenosum.
    Reich K; Vente C; Neumann C
    Br J Dermatol; 1998 Oct; 139(4):755-7. PubMed ID: 9892935
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine.
    D'Incà R; Fagiuoli S; Sturniolo GC
    Ann Intern Med; 1998 May; 128(9):783-4. PubMed ID: 9556483
    [No Abstract]   [Full Text] [Related]  

  • 7. Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus.
    Lyon CC; Kirby B; Griffiths CE
    Br J Dermatol; 1999 Mar; 140(3):562-4. PubMed ID: 10233300
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.
    Kimble RM; Tickler AK; Nicholls VS; Cleghorn G
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):555-7. PubMed ID: 12050584
    [No Abstract]   [Full Text] [Related]  

  • 9. Pustular penile pyoderma gangrenosum successfully treated with topical tacrolimus ointment.
    Larsen CG; Thyssen JP
    Acta Derm Venereol; 2012 Jan; 92(1):104-5. PubMed ID: 21681352
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic absorption of topical tacrolimus in Pyoderma gangrenosum.
    Pitarch G; Torrijos A; Mahiques L; Sánchez-Carazo JL; Fortea JM
    Acta Derm Venereol; 2006; 86(1):64-5. PubMed ID: 16585995
    [No Abstract]   [Full Text] [Related]  

  • 11. Is topical monotherapy effective for localized pyoderma gangrenosum?
    Le Cleach L; Moguelet P; Perrin P; Chosidow O
    Arch Dermatol; 2011 Jan; 147(1):101-3. PubMed ID: 21242400
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis.
    Baumgart DC; Wiedenmann B; Dignass AU
    Inflamm Bowel Dis; 2004 Jul; 10(4):421-4. PubMed ID: 15475751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.
    Marasca C; Fontanella G; Annunziata MC; Marasca D; Fabbrocini G
    Int Wound J; 2019 Aug; 16(4):1047-1048. PubMed ID: 30938050
    [No Abstract]   [Full Text] [Related]  

  • 14. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.
    Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G
    Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739
    [No Abstract]   [Full Text] [Related]  

  • 15. A Case Series of 4 Patients With Peristomal Pyoderma Gangrenosum: Review of Risk Factors and Treatment Response.
    Turrión-Merino L; Hermosa-Zarza E; Miguel L; Muñoz-Zato E
    Actas Dermosifiliogr; 2016 Apr; 107(3):e13-7. PubMed ID: 26626501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).
    Abu-Elmagd K; Van Thiel DH; Jegasothy BV; Jacobs JC; Carroll P; Rodriquez-Rilo H; Ackerman CD; Fung JJ; Starzl TE
    Ann Intern Med; 1993 Oct; 119(7 Pt 1):595-8. PubMed ID: 7689802
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of localized pyoderma gangrenosum with topical pimecrolimus.
    Cecchi R; Pavesi M; Bartoli L; Brunetti L
    J Cutan Med Surg; 2012; 16(5):295-7. PubMed ID: 22971301
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids.
    Doren EL; Aya-ay ML
    Aesthet Surg J; 2014 Mar; 34(3):394-9. PubMed ID: 24448967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of vulvar pyoderma gangrenosum associated with collagenous colitis.
    Roé E; Dalmau J; García-Navarro X; Corella F; Monfort D; Busquets D; Ribé A; Delgado E; Alomar A
    Dermatology; 2006; 213(3):234-5. PubMed ID: 17033174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial granulomatous pyoderma. Report of 2 cases treated with topical tacrolimus.
    Ormaechea-Pérez N; López-Pestaña A; Lobo-Morán C; Tuneu-Valls A
    Actas Dermosifiliogr; 2013 Oct; 104(8):721-4. PubMed ID: 23933249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.